Strides Pharma Science Limited has informed the Exchange regarding a press release dated February 24, 2023, titled "Strides flagship facility in Bangalore receives USFDA inspection closure".
Press Release Feb 24 2023
Filed with NSE ·
6ix hasn’t read this filing yet.
Strides Pharma Science Ltd on 6ix
Earlier from Strides Pharma Science
- Earnings Update_Q2FY23
- Earnings Update_Q3FY23
- Press Release Jan 20 2023
- Press Release Jan 18 2023
- Press Release Dec 28 2022
Later from Strides Pharma Science
- Strides Pharma Science Ltd Press Release May 03 2023
- Strides Pharma Science Ltd Press Release May 19 2023
- Press Release May 25 2023
- Press Release Jul 04 2023
- Intimation of Board Meeting scheduled on August 2, 2023
Follow Strides Pharma Science into a list and get an email when it puts out news.
Follow Strides Pharma Science